Cargando…

A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells

[Image: see text] Sickle cell disease is an inherited disorder of hemoglobin (Hb). During a sickle cell crisis, deoxygenated sickle hemoglobin (deoxyHbS) polymerizes to form fibers in red blood cells (RBCs), causing the cells to adopt “sickled” shapes. Using small molecules to increase the affinity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakagawa, Akito, Ferrari, Michele, Schleifer, Grigorij, Cooper, Marissa K., Liu, Chen, Yu, Binglan, Berra, Lorenzo, Klings, Elizabeth S., Safo, Ronni S., Chen, Qiukan, Musayev, Faik N., Safo, Martin K., Abdulmalik, Osheiza, Bloch, Donald B., Zapol, Warren M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942180/ https://www.ncbi.nlm.nih.gov/pubmed/29634905 http://dx.doi.org/10.1021/acs.molpharmaceut.8b00108

Ejemplares similares

Identification of a Small Molecule that Increases Hemoglobin Oxygen Affinity and Reduces SS Erythrocyte Sickling
por: Nakagawa, Akito, et al.
Publicado: (2014)

VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions
por: Abdulmalik, Osheiza, et al.
Publicado: (2020)

Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities
por: Alramadhani, Dina, et al.
Publicado: (2022)

Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin. Corrigendum
por: Abdulmalik, Osheiza, et al.
Publicado: (2011)

High-Throughput Assay to Screen Small Molecules for Their Ability to Prevent Sickling of Red Blood Cells
por: Nakagawa, Akito, et al.
Publicado: (2022)

Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell Disease
por: Alhashimi, Rana T., et al.
Publicado: (2022)

An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling
por: Omar, Abdelsattar M., et al.
Publicado: (2020)

Clinical Implications of the Association of Fetal Hemoglobin with Peripheral Oxygen Saturation in Sickle Cell Disease
por: Abdulmalik, Osheiza, et al.
Publicado: (2017)

Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell Disease
por: Huang, Boshi, et al.
Publicado: (2022)

Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia
por: Abdulmalik, Osheiza, et al.
Publicado: (2021)

Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients
por: Rab, Minke A.E., et al.
Publicado: (2019)

Improving the Solubility and Oral Bioavailability of a Novel Aromatic Aldehyde Antisickling Agent (PP10) for the Treatment of Sickle Cell Disease
por: Ahmed, Tarek A., et al.
Publicado: (2021)

Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin
por: Omar, Abdelsattar M., et al.
Publicado: (2016)

Sickle cell disease: wheeze or asthma?
por: Cohen, Robyn T., et al.
Publicado: (2015)

THE STATE OF HEMOGLOBIN IN SICKLED ERYTHROCYTES
por: Stetson, Chandler A.
Publicado: (1966)

X-ray crystallography and sickle cell disease drug discovery—a tribute to Donald Abraham
por: Donkor, Akua K., et al.
Publicado: (2023)

Sickle Cell Disease and Fetal Hemoglobin
por: Rivera, Alicia
Publicado: (2018)

Crystal Structures of Influenza A Virus Matrix Protein M1: Variations on a Theme
por: Safo, Martin K., et al.
Publicado: (2014)

Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
por: Klings, Elizabeth S, et al.
Publicado: (2001)

GELS OF NORMAL AND SICKLED HEMOGLOBIN : COMPARATIVE STUDY
por: White, James G., et al.
Publicado: (1970)

Common Complications of Sickle Cell Disease: A Simulation-Based Curriculum
por: Cramer-Bour, Cassondra, et al.
Publicado: (2021)

Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease
por: Sun, Kaiqi, et al.
Publicado: (2017)

Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015)

Rapid and inefficient kinetics of sickle hemoglobin fiber growth
por: Castle, Brian T., et al.
Publicado: (2019)

Hemoglobin level and macular thinning in sickle cell disease
por: Hussnain, S Amal, et al.
Publicado: (2019)

Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
por: Noubiap, Jean Jacques, et al.
Publicado: (2018)

Fluorescence Lifetime Measurement of Prefibrillar Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle Cell Disease
por: Vunnam, Nagamani, et al.
Publicado: (2022)

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling
por: De Souza, Daniel C., et al.
Publicado: (2023)

Inhibition of the Aquaporin-1 Cation Conductance by Selected Furan Compounds Reduces Red Blood Cell Sickling
por: Chow, Pak Hin, et al.
Publicado: (2022)

Inactive mutants of human pyridoxine 5′‐phosphate oxidase: a possible role for a noncatalytic pyridoxal 5′‐phosphate tight binding site
por: Ghatge, Mohini S., et al.
Publicado: (2016)

Molecular insight into 2-phosphoglycolate activation of the phosphatase activity of bisphosphoglycerate mutase
por: Aljahdali, Anfal S., et al.
Publicado: (2022)

THE PHYSICAL STATE OF HEMOGLOBIN IN SICKLE-CELL ANEMIA ERYTHROCYTES IN VIVO
por: Döbler, Johanna, et al.
Publicado: (1968)

Sickle Retinopathy in a Person with Hemoglobin S/New York Disease
por: Calder, Donovan, et al.
Publicado: (2012)

The Sickle Effect: The Silent Titan Affecting Glycated Hemoglobin Reliability
por: Gordon, Domonick K, et al.
Publicado: (2020)

Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease
por: El Hoss, Sara, et al.
Publicado: (2020)

Hemoglobin and End-Organ Damage in Individuals with Sickle Cell Disease
por: Ershler, William B., et al.
Publicado: (2023)

Substitutions in the β subunits of sickle-cell hemoglobin improve oxidative stability and increase the delay time of sickle-cell fiber formation
por: Meng, Fantao, et al.
Publicado: (2019)

An “acquired” hemoglobin J variant in a sickle cell disease patient
por: Swedan, Nawwar, et al.
Publicado: (2008)

The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
por: Castro, O., et al.
Publicado: (1974)

Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia
por: Eridani, Sandro, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_crirkog4jje26qn2ds5gjlja50